Paul Jonathan Clewlow

Part of ICON plc, Medeval Group Ltd. is a British company that carries out clinical pharmacology studies on behalf of pharmaceutical and biotechnology companies. The company is based in Manchester, UK. Medeval Group was acquired by ICON plc on January 24, 2003 for $22.64 million.

Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom.

Pharmaceutical Profiles Ltd. develops drugs for pharmaceutical and biotech companies. The company studies how drugs are absorbed and processed in the human body. It utilizes gamma camera imaging products in its studies. It also provides complete scientific, regulatory and medical support for its client's clinical development programs. Pharmaceutical Profiles was founded in 1990 and is headquartered in Nottingham, UK.

Sygnature Discovery Ltd. engages in drug discovery activities. It specializes in target validation, hit identification, hit to lead, lead optimization, integrated drug discovery, and fragment based drug discovery. The company was founded by Simon Christopher Hirst in 2004 and is headquartered in Nottingham, United Kingdom.

Part of Aghoco (1579) Topco Ltd., Evergreen Holdco 1 Ltd. operates as a holding British company with subsidiaries that engage in research and experimental development on biotechnology. The company is based in Nottingham, UK.

Part of Aghoco (1579) Topco Ltd., Aghoco 1566 (Bidco) Ltd. functions as an investment holding British company. The company is based in Nottingham, UK.

Part of Evergreen Holdco 2 Ltd., Sygil Group Ltd. is a holding British company that provides drug discovery services. The company is based in Nottingham, UK and was founded in 2011.

Aghoco (1579) Topco Ltd. is a British biotechnology company founded in 2017. The private company is based in Nottingham, UK. and has subsidiaries in United Kingdom. Aghoco engages in research and development in biotechnology.

Part of Aghoco (1579) Topco Ltd., Aghoco 1578 (Midco) Ltd. operates as a holding British company whose subsidiary manufactures drugs. The company is based in Nottingham, UK and was founded in 2017.